undamentalytics Newsletter
Sign in

Agilon Health, Inc. key statistics and ratios

In fiscal 2025, Agilon Health, Inc. had return on equity of -131.0%, an operating margin of -7.8%, debt equal to 27.6% of equity and a current ratio of 1.02. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Operating margin−13.4%−4.7%−24.5%−4.4%−5.4%−4.8%−7.8%−5.2%
Net margin−35.6%−4.9%−26.7%−4.5%−6.1%−4.3%−6.6%−3.9%
Free-cash-flow margin−13.4%−4.5%−10.2%−6.1%−4.0%−1.2%−2.0%−1.4%
Return on equity——−100.7%−10.0%−30.8%−45.9%−131.0%−131.1%
Return on assets—−13.5%−40.0%−6.5%−15.3%−15.0%−26.0%−16.2%
Asset turnover—2.731.501.452.513.493.954.14
Current ratio—1.103.832.711.511.271.021.08
Debt to equity——4.5%4.2%5.9%7.4%27.6%13.3%
Interest cover (operating income ÷ interest)n/mn/mn/mn/mn/mn/mn/mn/m
Capital spending as % of revenue0.4%0.1%0.4%0.6%0.4%0.2%0.2%0.2%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

4 of 7 checks passed · June 30, 2026
What it owns · $1.6bn
Short-term assets $1.4bnLonger-term assets $173m
What it owes, and who funded it · $1.6bn
Short-term liabilities $1.3bnLonger-term liabilities $51mShareholders' equity $228m
  • Short-term assets cover short-term liabilities $1.4bn of assets due within a year against $1.3bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.4bn short-term assets against $51m of longer-dated liabilities.
  • More cash than debt $107m of cash against $30m of debt.
  • Debt below 40% of shareholders' equity Debt is 13% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 4% to 13% over five years.
  • A year's operating cash flow covers at least 20% of debt −$72m of operating cash flow against $30m of debt.
  • Operating profit covers interest at least five times over Operating income of −$309m against $7m of interest.

From Agilon Health, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

12 /100

Weak moat

How hard Agilon Health's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -14.2% of total assets over 6 years.

  • Durability 10 / 20

    Operating margin has been a median -5.0%; its worst year was -23.3%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 6 years, at a median -3.7% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (17 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: AGL vs OPCHAGL vs ASTHAGL vs AMN

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Agilon Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agilon Health, Inc.